AAAAAA

   
Results: 1-10 |
Results: 10
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer
Authors: Levitt, NC Eskens, FALM O'Byrne, KJ Propper, DJ Denis, LJ Owen, SJ Choi, L Foekens, JA Wilner, S Wood, JM Nakajima, M Talbot, DC Steward, WP Harris, AL Verweij, J
Citation: Nc. Levitt et al., Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer, CLIN CANC R, 7(7), 2001, pp. 1912-1922
Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors
Authors: Eskens, FALM Greim, GA van Zuylen, C Wolff, I Denis, LJ Planting, AST Muskiet, FA Wanders, J Barbet, NC Choi, L Capdeville, R Verweij, J Hanauske, AR Bruntsch, U
Citation: Falm. Eskens et al., Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors, CLIN CANC R, 6(5), 2000, pp. 1736-1743
Effect of food on the pharmacokinetics of oral MMI270B (CGS 27023A), a novel matrix metalloproteinase inhibitor
Authors: Eskens, FALM Levitt, NC Sparreboom, A Choi, L Mather, R Verweij, J Harris, AL
Citation: Falm. Eskens et al., Effect of food on the pharmacokinetics of oral MMI270B (CGS 27023A), a novel matrix metalloproteinase inhibitor, CLIN CANC R, 6(2), 2000, pp. 431-433
Compiler analysis for cache coherence: Interprocedural array data-flow analysis and its impact on cache performance
Authors: Choi, L Yew, PC
Citation: L. Choi et Pc. Yew, Compiler analysis for cache coherence: Interprocedural array data-flow analysis and its impact on cache performance, IEEE PARALL, 11(9), 2000, pp. 879-896
Hardware and compiler-directed cache coherence in large-scale multiprocessors: Design considerations and performance study
Authors: Choi, L Yew, PC
Citation: L. Choi et Pc. Yew, Hardware and compiler-directed cache coherence in large-scale multiprocessors: Design considerations and performance study, IEEE PARALL, 11(4), 2000, pp. 375-394
Population pharmacokinetics/toxicodynamics (PK/TD) relationship of SAM486Ain phase I studies in patients with advanced cancers
Authors: Zhou, HH Choi, L Lau, H Bruntsch, U De Vries, EEGE Eckhardt, G Van Oosterom, AT Verweij, J Schran, H Barbet, N Linnartz, R Capdeville, R
Citation: Hh. Zhou et al., Population pharmacokinetics/toxicodynamics (PK/TD) relationship of SAM486Ain phase I studies in patients with advanced cancers, J CLIN PHAR, 40(3), 2000, pp. 275-283
A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours
Authors: Paridaens, R Uges, DRA Barbet, N Choi, L Seeghers, M van der Graaf, WTA Groen, HJM Dumez, H Van Buuren, I Muskiet, F Capdeville, R van Oosterom, AT de Vries, EGE
Citation: R. Paridaens et al., A phase I study of a new polyamine biosynthesis inhibitor, SAM486A, in cancer patients with solid tumours, BR J CANC, 83(5), 2000, pp. 594-601
Pilot study of guided imagery use in patients with severe heart failure
Authors: Klaus, L Beniaminovitz, A Choi, L Greenfield, F Whitworth, GC Oz, MC Mancini, DM
Citation: L. Klaus et al., Pilot study of guided imagery use in patients with severe heart failure, AM J CARD, 86(1), 2000, pp. 101
Development of an infection-resistant LVAD driveline: A novel approach to the prevention of device-related infections
Authors: Choi, L Choudhri, AF Pillarisetty, VG Sampath, LA Caraos, L Brunnert, SR Oz, MC Modak, SM
Citation: L. Choi et al., Development of an infection-resistant LVAD driveline: A novel approach to the prevention of device-related infections, J HEART LUN, 18(11), 1999, pp. 1103-1110
Pharmacokinetics and organ distribution of cyclosporin A incorporated in liposomes and mixed micelles
Authors: Lee, MK Choi, L Kim, MH Kim, CK
Citation: Mk. Lee et al., Pharmacokinetics and organ distribution of cyclosporin A incorporated in liposomes and mixed micelles, INT J PHARM, 191(2), 1999, pp. 87-93
Risultati: 1-10 |